400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / GPCR/G Protein / GPCR / (S)-2-(6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid
CAS No.: 1000413-72-8
Synonyms: TAK-875
TAK-875 is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 0.072 μM.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01433393 | Diabetes Mellitus | Phase 3 | Completed | - | Japan ... more >> Kisarazu-shi, Chiba, Japan Matsuyama-shi, Ehime, Japan Fukuoka-shi Nishi-ku, Fukuoka, Japan Kasuga-shi, Fukuoka, Japan Naka-shi, Ibaragi, Japan Tsuchiura-shi, Ibaragi, Japan Takamatsu-shi, Kagawa, Japan Kyoto-shi Fushimi-ku, Kyoto, Japan Nagasaki-shi, Nagasaki, Japan Kashihara-shi, Nara, Japan Kashiwara-shi, Osaka, Japan Osaka-shi Tsurumi-ku, Osaka, Japan Sakai-shi Nishi-ku, Osaka, Japan Shimotsuke-shi, Tochigi, Japan Chiyoda-ku, Tokyo, Japan Itabashi-ku, Tokyo, Japan Ota-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Toshima-ku, Tokyo, Japan Collapse << |
NCT01585792 | Diabetic Patients | Phase 3 | Completed | - | Japan ... more >> Fukuoka-shi, Fukuoka, Japan Sumida-ku, Tokyo, Japan Collapse << |
NCT01007097 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
实验方案
技术信息
CAS号 | 1000413-72-8 | 储存条件 |
|
|||||
分子式 | C29H32O7S | 运输 | 蓝冰 | |||||
分子量 | 524.63 | 别名 | TAK-875 | |||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01433393 | Diabetes Mellitus | Phase 3 | Completed | - | Japan ... more >> Kisarazu-shi, Chiba, Japan Matsuyama-shi, Ehime, Japan Fukuoka-shi Nishi-ku, Fukuoka, Japan Kasuga-shi, Fukuoka, Japan Naka-shi, Ibaragi, Japan Tsuchiura-shi, Ibaragi, Japan Takamatsu-shi, Kagawa, Japan Kyoto-shi Fushimi-ku, Kyoto, Japan Nagasaki-shi, Nagasaki, Japan Kashihara-shi, Nara, Japan Kashiwara-shi, Osaka, Japan Osaka-shi Tsurumi-ku, Osaka, Japan Sakai-shi Nishi-ku, Osaka, Japan Shimotsuke-shi, Tochigi, Japan Chiyoda-ku, Tokyo, Japan Itabashi-ku, Tokyo, Japan Ota-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Toshima-ku, Tokyo, Japan Collapse << |
NCT01585792 | Diabetic Patients | Phase 3 | Completed | - | Japan ... more >> Fukuoka-shi, Fukuoka, Japan Sumida-ku, Tokyo, Japan Collapse << |
NCT01007097 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01433406 | Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01414920 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01433419 | Diabetes Mellitus | Phase 3 | Completed | - | Japan ... more >> Katori-shi, Chiba, Japan Niihama-shi, Ehime, Japan Chikushino-shi, Fukuoka, Japan Fukuoka-shi, Fukuoka, Japan Onga-gun, Fukuoka, Japan Yukuhashi-shi, Fukuoka, Japan Hiroshima-shi, Hiroshima, Japan Chitose-shi, Hokkaido, Japan Sapporo-shi, Hokkaido, Japan Koga-shi, Ibaragi, Japan Ushiku-shi, Ibaragi, Japan Chigasaki-shi, Kanagawa, Japan Kamakura-shi, Kanagawa, Japan Minamata-shi, Kumamoto, Japan Yatsushiro-shi, Kumamoto, Japan Sasebo-shi, Nagasaki, Japan Kashihara-shi, Nara, Japan Okinawa-shi, Okinawa, Japan Izumi-shi, Osaka, Japan Suita-shi, Osaka, Japan Fujimi-shi, Saitama, Japan Shimotsuga-gun, Tochigi, Japan Komatsushima-shi, Tokushima, Japan Bunkyo-ku, Tokyo, Japan Chiyoda-ku, Tokyo, Japan Mitaka-shi, Tokyo, Japan Shibuya-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Toshima-ku, Tokyo, Japan Shunan-shi, Yamaguchi, Japan Ube-shi, Yamaguchi, Japan Collapse << |
NCT01456195 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01549964 | Glycemic Control | Phase 3 | Terminated(Due to concerns abo... more >>ut potential liver safety (See Detailed Description)) Collapse << | - | - |
NCT01834274 | Diabetes Mellitus, Type 2 | Phase 3 | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01834274 | - | - | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01982253 | Type 2 Diabetes Mellitus | Phase 2 | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01982253 | - | - | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01481116 | - | - | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01549964 | - | - | Terminated(Due to concerns abo... more >>ut potential liver safety (See Detailed Description)) Collapse << | - | - |
NCT02015780 | Type 2 Diabetes Mellitus ... more >> Chronic Kidney Disease Collapse << | Phase 3 | Withdrawn(Due to potential con... more >>cerns about liver safety (See Detailed Description)) Collapse << | January 2016 | - |
NCT01481116 | Diabetes Mellitus, Type 2 | Phase 3 | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01456195 | - | - | Completed | - | - |
NCT01829464 | Diabetes | Phase 3 | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01829477 | Diabetes Mellitus, Type 2 | Phase 3 | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT00949091 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | - |
NCT01496443 | Pharmacokinetics | Phase 1 | Completed | - | United States, Texas ... more >> San Antonio, Texas, United States Collapse << |
NCT01829477 | - | - | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01647542 | Type 2 Diabetes Mellitus | Phase 3 | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01647542 | - | - | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01609582 | - | - | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01829464 | - | - | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
NCT01609582 | Type 2 Diabetes ... more >> Cardiovascular Disease Collapse << | Phase 3 | Terminated(Due to potential co... more >>ncerns about liver safety (See Detailed Description)) Collapse << | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网